These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 8713577)
1. The inhibition of human factor VIIa-tissue factor by antithrombin III-heparin is enhanced by factor X on a human bladder carcinoma cell line. Hamamoto T; Foster DC; Kisiel W Int J Hematol; 1996 Jan; 63(1):51-63. PubMed ID: 8713577 [TBL] [Abstract][Full Text] [Related]
2. Mechanism of antithrombin III inhibition of factor VIIa/tissue factor activity on cell surfaces. Comparison with tissue factor pathway inhibitor/factor Xa-induced inhibition of factor VIIa/tissue factor activity. Rao LV; Nordfang O; Hoang AD; Pendurthi UR Blood; 1995 Jan; 85(1):121-9. PubMed ID: 7803789 [TBL] [Abstract][Full Text] [Related]
3. Complex-dependent inhibition of factor VIIa by antithrombin III and heparin. Lawson JH; Butenas S; Ribarik N; Mann KG J Biol Chem; 1993 Jan; 268(2):767-70. PubMed ID: 8419351 [TBL] [Abstract][Full Text] [Related]
4. The effect of heparin on the regulation of factor VIIa-tissue factor activity by tissue factor pathway inhibitor. Hamamoto T; Kisiel W Blood Coagul Fibrinolysis; 1996 Jun; 7(4):470-6. PubMed ID: 8840000 [TBL] [Abstract][Full Text] [Related]
5. Binding of factor VIIa to tissue factor permits rapid antithrombin III/heparin inhibition of factor VIIa. Rao LV; Rapaport SI; Hoang AD Blood; 1993 May; 81(10):2600-7. PubMed ID: 8490170 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory properties of full-length and truncated recombinant tissue factor pathway inhibitor (TFPI). Evidence that the third Kunitz-type domain of TFPI is not essential for the inhibition of factor VIIa-tissue factor complexes on cell surfaces. Hamamoto T; Yamamoto M; Nordfang O; Petersen JG; Foster DC; Kisiel W J Biol Chem; 1993 Apr; 268(12):8704-10. PubMed ID: 8473315 [TBL] [Abstract][Full Text] [Related]
7. Initiation of the tissue factor pathway of coagulation in the presence of heparin: control by antithrombin III and tissue factor pathway inhibitor. Jesty J; Lorenz A; Rodriguez J; Wun TC Blood; 1996 Mar; 87(6):2301-7. PubMed ID: 8630391 [TBL] [Abstract][Full Text] [Related]
8. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II. van 't Veer C; Mann KG J Biol Chem; 1997 Feb; 272(7):4367-77. PubMed ID: 9020158 [TBL] [Abstract][Full Text] [Related]
9. The effect of cell surface glycosaminoglycans (GAGs) on the inactivation of factor VIIa--tissue factor activity by antithrombin III. Hamamoto T; Kisiel W Int J Hematol; 1998 Jul; 68(1):67-78. PubMed ID: 9713170 [TBL] [Abstract][Full Text] [Related]
10. Antithrombin-mediated inhibition of factor VIIa-tissue factor complex by the synthetic pentasaccharide representing the heparin binding site to antithrombin. Lormeau JC; Herault JP; Herbert JM Thromb Haemost; 1996 Jul; 76(1):5-8. PubMed ID: 8819242 [TBL] [Abstract][Full Text] [Related]
11. Regulation of factor VIIa activity in plasma: evidence that antithrombin III is the sole plasma protease inhibitor of human factor VIIa. Kondo S; Kisiel W Thromb Res; 1987 Apr; 46(2):325-35. PubMed ID: 3496682 [TBL] [Abstract][Full Text] [Related]
12. Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor.VIIa with Xa.tissue factor pathway inhibitor. Rao LV; Ruf W Biochemistry; 1995 Aug; 34(34):10867-71. PubMed ID: 7662667 [TBL] [Abstract][Full Text] [Related]
13. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors. Lämmle B; Griffin JH Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929 [TBL] [Abstract][Full Text] [Related]
14. Recent advances in the discovery of tissue factor/factor VIIa inhibitors and dual inhibitors of factor VIIa/factor Xa. Kranjc A; Kikelj D; Peterlin-Masic L Curr Pharm Des; 2005; 11(32):4207-27. PubMed ID: 16375741 [TBL] [Abstract][Full Text] [Related]
15. Protease nexin-2/Amyloid beta-protein precursor regulates factor VIIa and the factor VIIa-tissue factor complex. Mahdi F; Rehemtulla A; Van Nostrand WE; Bajaj SP; Schmaier AH Thromb Res; 2000 Aug; 99(3):267-76. PubMed ID: 10942793 [TBL] [Abstract][Full Text] [Related]
16. The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor. Ofosu FA; Cerskus AL; Hirsh J; Smith LM; Modi GJ; Blajchman MA Br J Haematol; 1984 Jun; 57(2):229-38. PubMed ID: 6733045 [TBL] [Abstract][Full Text] [Related]
17. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action. Broze GJ; Warren LA; Novotny WF; Higuchi DA; Girard JJ; Miletich JP Blood; 1988 Feb; 71(2):335-43. PubMed ID: 3422166 [TBL] [Abstract][Full Text] [Related]
18. Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation. Rao LV; Rapaport SI Proc Natl Acad Sci U S A; 1988 Sep; 85(18):6687-91. PubMed ID: 3261869 [TBL] [Abstract][Full Text] [Related]
19. Neutralization and binding of heparin by S protein/vitronectin in the inhibition of factor Xa by antithrombin III. Involvement of an inducible heparin-binding domain of S protein/vitronectin. Preissner KT; Müller-Berghaus G J Biol Chem; 1987 Sep; 262(25):12247-53. PubMed ID: 2442161 [TBL] [Abstract][Full Text] [Related]
20. Evidence for a plasma inhibitor of the heparin accelerated inhibition of factor Xa by antithrombin III. MacGregor IR; Lane DA; Kakkar VV Biochim Biophys Acta; 1979 Sep; 586(3):584-93. PubMed ID: 476156 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]